Danaher Corporation
General ticker "DHR" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $169.6B
Danaher Corporation follows the US Stock Market performance with the rate: 29.4%.
Estimated limits based on current volatility of 1.0%: low 226.83$, high 231.57$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-09-27, amount 0.27$ (Y0.47%)
- China accounted for 13.2% of revenue in the fiscal year ended 2023-12-31
- US accounted for 40.1% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [216.15$, 303.84$]
- 2024-12-30 to 2025-12-30 estimated range: [245.02$, 338.48$]
Financial Metrics affecting the DHR estimates:
- Positive: Non-GAAP EPS, $ of 8.52 > 2.29
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: Operating profit margin, % of 21.77 > 19.51
- Negative: Operating cash flow per share per price, % of 4.34 <= 7.18
Short-term DHR quotes
Long-term DHR plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $24,802.00MM | $26,643.00MM | $23,890.00MM |
| Operating Expenses | $18,425.00MM | $19,107.00MM | $18,688.00MM |
| Operating Income | $6,377.00MM | $7,536.00MM | $5,202.00MM |
| Non-Operating Income | $134.00MM | $-390.00MM | $-158.00MM |
| Interest Expense | $238.00MM | $211.00MM | $286.00MM |
| R&D Expense | $1,742.00MM | $1,745.00MM | $1,503.00MM |
| Income(Loss) | $6,511.00MM | $7,146.00MM | $5,044.00MM |
| Taxes | $1,064.00MM | $818.00MM | $823.00MM |
| Other Income(Loss) | $986.00MM | $881.00MM | $543.00MM |
| Profit(Loss) | $6,433.00MM | $7,209.00MM | $4,764.00MM |
| Stockholders Equity | $45,167.00MM | $50,082.00MM | $53,486.00MM |
| Inventory | $2,767.00MM | $3,110.00MM | $2,594.00MM |
| Assets | $83,184.00MM | $84,350.00MM | $84,488.00MM |
| Operating Cash Flow | $8,358.00MM | $8,519.00MM | $7,164.00MM |
| Capital expenditure | $1,294.00MM | $1,152.00MM | $1,383.00MM |
| Investing Cash Flow | $-12,987.00MM | $-2,234.00MM | $-7,081.00MM |
| Financing Cash Flow | $1,295.00MM | $-2,570.00MM | $-273.00MM |
| Earnings Per Share* | $8.77 | $9.80 | $6.44 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.